Paaladinesh Thavendiranathan1, Tomoko Negishi2, Marc-Andre Coté3, Martin Penicka4, Richard Massey5, Goo-Yeong Cho6, Krassimira Hristova7, Dragos Vinereanu8, Bogdan A Popescu8, Masaki Izumo9, Kazuaki Negishi2, Thomas H Marwick10. 1. Toronto General Hospital, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, University of Toronto, Toronto, Canada. 2. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. 3. Centre de recherche du CHU de Québec, Québec, Canada. 4. Cardiovascular Center Aalst, OLV Clinic, Belgium, Aalst, Belgium. 5. Oslo University Hospital, Oslo, Norway. 6. Seoul National University, Bundang Hospital, Seoul, Republic of Korea. 7. National Heart Hospital, Sofia, Bulgaria. 8. University of Medicine and Pharmacy Carol Davila, Bucharest, Romania. 9. St. Marianna University School of Medicine, Kawasaki, Japan. 10. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia; Baker Heart & Diabetes Institute, Melbourne, Australia. Electronic address: tom.marwick@bakeridi.edu.au.
Abstract
OBJECTIVES: The goal of this study was to compare echocardiographic measurements of global longitudinal strain (GLS) (using 3 apical views) with single-view longitudinal strain (LS, 4- or 2-chamber [4CV_LS and 2CV_LS, respectively]) for detection of cancer-therapy related cardiotoxicity. BACKGROUND:GLS is useful for the detection of cardiotoxicity, but the need for repeated measurements poses a significant burden on busy echocardiography laboratories. A single-view LS measurement, possibly at point of care, could improve efficiency. METHODS:Seventeen international centers prospectively recruited 108 patients (mean age 54 ± 13 years) at high risk for cardiotoxicity as part of the ongoing SUCCOUR (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy) randomized controlled trial. Echocardiography performed at baseline and follow-up were analyzed in a core laboratory setting blinded to clinical information. Peak systolic GLS and LS were measured from raw data. Cardiotoxicity was defined by reduction in left ventricular ejection fraction >0.10 to <0.55 or a relative drop in GLS by ≥12%. RESULTS:Cardiotoxicity developed in 46 patients by either criteria. Baseline and follow-up 2-dimensional left ventricular ejection fraction were 61 ± 4% and 58 ± 5%, respectively (p < 0.001). The baseline GLS (-20.9 ± 2.4%) was not different from 4CV_LS (-20.7 ± 2.5%; p = 0.09) or 2CV_LS (-21.1 ± 3.1%; p = 0.25). The follow-up GLS (-19.5 ± 2.4%) was also similar to 4CV_LS (-19.5 ± 2.6%; p = 0.80) and 2CV_LS (-19.7 ± 3.1%; p = 0.19). There was good correlation between GLS and 4CV_LS at baseline (r = 0.86; p < 0.001) and follow-up (r = 0.89; p < 0.001) and with 2CV_LS at baseline (r = 0.87; p < 0.001) and follow-up (r = 0.88; p < 0.001). However, there was 15% to 22% disagreement between GLS and 4CV_LS or 2CV_LS for the detection of cardiotoxicity. The interobserver and intraobserver reproducibility was higher for GLS (intraclass correlation: 0.93 to 0.95; coefficient of variance: 2.9% to 3.7%) compared with either single-chamber-based LS measurement (intraclass correlation: 0.85 to 0.91; coefficient of variance: 4.1% to 4.8%). CONCLUSIONS: Although there was good correlation between GLS and single-view LS measurements, single-view LS measurement led to disagreement in the diagnosis of cardiotoxicity in up to 22% of patients. GLS measurements were more reproducible than single-view LS. GLS based on 3 apical views should remain the preferred technique for detection of cardiotoxicity. (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy [SUCCOUR]; ACTRN12614000341628).
RCT Entities:
OBJECTIVES: The goal of this study was to compare echocardiographic measurements of global longitudinal strain (GLS) (using 3 apical views) with single-view longitudinal strain (LS, 4- or 2-chamber [4CV_LS and 2CV_LS, respectively]) for detection of cancer-therapy related cardiotoxicity. BACKGROUND: GLS is useful for the detection of cardiotoxicity, but the need for repeated measurements poses a significant burden on busy echocardiography laboratories. A single-view LS measurement, possibly at point of care, could improve efficiency. METHODS: Seventeen international centers prospectively recruited 108 patients (mean age 54 ± 13 years) at high risk for cardiotoxicity as part of the ongoing SUCCOUR (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy) randomized controlled trial. Echocardiography performed at baseline and follow-up were analyzed in a core laboratory setting blinded to clinical information. Peak systolic GLS and LS were measured from raw data. Cardiotoxicity was defined by reduction in left ventricular ejection fraction >0.10 to <0.55 or a relative drop in GLS by ≥12%. RESULTS:Cardiotoxicity developed in 46 patients by either criteria. Baseline and follow-up 2-dimensional left ventricular ejection fraction were 61 ± 4% and 58 ± 5%, respectively (p < 0.001). The baseline GLS (-20.9 ± 2.4%) was not different from 4CV_LS (-20.7 ± 2.5%; p = 0.09) or 2CV_LS (-21.1 ± 3.1%; p = 0.25). The follow-up GLS (-19.5 ± 2.4%) was also similar to 4CV_LS (-19.5 ± 2.6%; p = 0.80) and 2CV_LS (-19.7 ± 3.1%; p = 0.19). There was good correlation between GLS and 4CV_LS at baseline (r = 0.86; p < 0.001) and follow-up (r = 0.89; p < 0.001) and with 2CV_LS at baseline (r = 0.87; p < 0.001) and follow-up (r = 0.88; p < 0.001). However, there was 15% to 22% disagreement between GLS and 4CV_LS or 2CV_LS for the detection of cardiotoxicity. The interobserver and intraobserver reproducibility was higher for GLS (intraclass correlation: 0.93 to 0.95; coefficient of variance: 2.9% to 3.7%) compared with either single-chamber-based LS measurement (intraclass correlation: 0.85 to 0.91; coefficient of variance: 4.1% to 4.8%). CONCLUSIONS: Although there was good correlation between GLS and single-view LS measurements, single-view LS measurement led to disagreement in the diagnosis of cardiotoxicity in up to 22% of patients. GLS measurements were more reproducible than single-view LS. GLS based on 3 apical views should remain the preferred technique for detection of cardiotoxicity. (Strain Surveillance for Improving Cardiovascular Outcomes During Chemotherapy [SUCCOUR]; ACTRN12614000341628).
Authors: Jan M Leerink; Esmée C de Baat; Remy Merkx; Elizabeth A M Feijen; Wouter E M Kok; Annelies M C Mavinkurve-Groothuis; Jacqueline Loonen; Helena J H van der Pal; Louise Bellersen; Chris L de Korte; Leontien C M Kremer; Elvira C van Dalen; Livia Kapusta Journal: J Cancer Surviv Date: 2021-03-27 Impact factor: 4.442
Authors: Remy Merkx; Jan M Leerink; Elisabeth Lieke A M Feijen; Leontien C M Kremer; Esmée C de Baat; Louise Bellersen; Elvira C van Dalen; Eline van Dulmen-den Broeder; Margriet van der Heiden-van der Loo; Marry M van den Heuvel-Eibrink; Chris L de Korte; Jacqueline Loonen; Marloes Louwerens; Angela H E M Maas; Yigal M Pinto; Cécile M Ronckers; Arco J Teske; Wim J E Tissing; Andrica C H de Vries; Annelies M C Mavinkurve-Groothuis; Helena J H van der Pal; Gert Weijers; Wouter E M Kok; Livia Kapusta Journal: Echocardiography Date: 2021-05-20 Impact factor: 1.724
Authors: Milanthy Pourier; Remy Merkx; Jacqueline Loonen; Alyssa van Cleef; Chris de Korte; Louise Bellersen; Livia Kapusta; Annelies Mavinkurve-Groothuis Journal: Life (Basel) Date: 2022-03-19